TIFFANY SIMON: Open Payments
NPI 1730561671 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,387 in 57 payments from 19 companies in 2025. Trend: 2023 $1,612 · 2024 $2,200 · 2025 $2,387
Food & beverage: $2,387
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 10 | $335 |
| ABBVIE INC. | 10 | $319 |
| Lilly USA, LLC | 2 | $244 |
| AstraZeneca Pharmaceuticals LP | 5 | $179 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $175 |
| Medtronic, Inc. | 1 | $167 |
| Gilead Sciences, Inc. | 3 | $163 |
| Amgen Inc. | 5 | $160 |
| Dexcom, Inc. | 2 | $153 |
| Astellas Pharma US Inc | 5 | $126 |
Products named: FREESTYLE LIBRE 3, BREZTRI, Kerendia, COREVALVE EVOLUT R, VRAYLAR, DEXCOM G7 GSS (161), QULIPTA, KRYSTEXXA.
Industry payments across LA — which companies pay providers there.
